NCT01217970View on ClinicalTrials.gov

Safety Interaction Trial Ibudilast and Methamphetamine

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Methamphetamine-dependenceSubstance Abuse
Interventions
DRUG

Ibudilast 20mg

Ibudilast 20mg BID

DRUG

Ibudilast 50mg

Ibudilast 50mg BID

DRUG

Placebo oral tablet

Trial Locations (1)

90502

Harbor-UCLA Medical Center GCRC, Torrance

Sponsors

Collaborators (1)

MediciNova
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

MediciNova

INDUSTRY

lead

University of California, Los Angeles

OTHER